Actavis Sues Sandoz, Hetero Over Generic Prostate Drug
By Dan Prochilo ( June 19, 2013, 1:08 PM EDT) -- Kissei Pharmaceutical Co. Ltd. and Actavis Inc. said Monday in virtually identical suits filed in Delaware federal court that Sandoz Inc. and Hetero Labs Ltd. infringed a patent for their enlarged-prostate drug by seeking approval for generic forms of the treatment....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.